MicroRNA-185 reduces the expression of hepatitis B virus surface antigen by targeting PRKCH in HepG2 2.2.15 cells

Acta Virol. 2020;64(3):297-306. doi: 10.4149/av_2020_304.

Abstract

MicroRNAs (miRNAs) are single-stranded noncoding RNAs with 18 to 25 nucleotides and play critical roles in a wide spectrum of biological processes. We repored that miR-185 inhibited hepatitis B surface antigen (HBsAg) expression and hepatitis B virus (HBV) replication without affecting the proliferation of HepG2 2.2.15 cells, compared with the controls. We identified that protein kinase C eta (PRKCH) is a direct target gene of miR-185 that affects HBV replication and protein expression and that the miR-185 may suppress HBV replication. Our results provide more information for gene therapy in HBV infection. Keywords: miR-185; HBV; HBV surface antigen; viral replication; PRKCH.

MeSH terms

  • Gene Expression Regulation, Viral
  • Hep G2 Cells
  • Hepatitis B / genetics*
  • Hepatitis B / therapy
  • Hepatitis B Surface Antigens / genetics*
  • Hepatitis B virus / physiology
  • Humans
  • MicroRNAs / genetics*
  • Protein Kinase C / genetics*
  • Virus Replication

Substances

  • Hepatitis B Surface Antigens
  • MIRN185 microRNA, human
  • MicroRNAs
  • PRKCH protein, human
  • Protein Kinase C